Citation: Kefurong Deng, Yachao Li, Xiaoyu Liang, Cheng Shen, Zenan Zeng, Xianghui Xu. Virus-inspired nanoparticles as versatile antibacterial carriers for antibiotic delivery against Gram-negative and Gram-positive bacteria[J]. Chinese Chemical Letters, ;2022, 33(3): 1619-1622. doi: 10.1016/j.cclet.2021.09.045 shu

Virus-inspired nanoparticles as versatile antibacterial carriers for antibiotic delivery against Gram-negative and Gram-positive bacteria

Department of Pharmacy, College of Biology, Hunan University, Changsha 410082, China

yachao_li@hotmail.com

xianghui.xu@hnu.edu.cn

xianghui.xu@hotmail.com

Received Date: 15 June 2021
Revised Date: 10 September 2021
Accepted Date: 13 September 2021
Available Online: 20 September 2021

Figures(5)

Infectious diseases become one of the leading causes of human death. Traditional treatment based on classical antibiotics could not provide enough antibacterial activity to combat bacterial infections due to low bioavailability, even leading to antibiotic resistance. In recent years, biomimetic delivery systems have been developed to improve drug therapy for various diseases, such as malignant tumor and cardiovascular disease. In this work, we designed virus-inspired nanodrugs (VNDs) through co-assembly of amphiphilic lipopeptide dendrons and poly(lactic-co-glycolic acid) polymers for high-efficiency antibiotic delivery. These VNDs had well-defined and stable nanostructures for tetracycline encapsulation and delivery. The VNDs were capable of promoting antibiotic internalization and enhancing their antibacterial effects against Gram-negative Escherichia coli and Gram-positive Staphylococcus aureus. Additionally, no obvious cytotoxicity of VNDs was observed to human cell lines. This work successfully demonstrated the virus-mimetic nanoparticles served as promising and applicable antibiotic delivery platform for antibacterial treatment.
- Virus-inspired nanoparticles,
- Bacterial intracellular drug delivery,
- Antibacterial treatment,
- Gram-positive bacteria,
- Gram-negative bacteria
1. [1]
  WHO, No time to wait: Securing the future from drug-resistant infections, https://www.who.int/antimicrobial-resistance/interagency-coordination-group/final-report/en/ (accessed April 2019).
2. [2]
  M.A. Kohanski, D.J. Dwyer, J.J. Collins, Nat. Rev. Microbiol. 8 (2010) 423–435 doi: 10.1038/nrmicro2333
3. [3]
  W. Li, F. Separovic, N.M. O'Brien-Simpson, J.D. Wade, Chem. Soc. Rev. 50 (2021) 4932–4973 doi: 10.1039/d0cs01026j
4. [4]
  W. Gao, S. Thamphiwatana, P. Angsantikul, L. Zhang, WIREs Nanomed. Nanobiotechnol. 6 (2014) 532–547 doi: 10.1002/wnan.1282
5. [5]
  S. Menina, J. Eisenbeis, M.A.M. Kamal, et al., Adv. Healthcare Mater. 8 (2019) 1900564 doi: 10.1002/adhm.201900564
6. [6]
  M.H. Xiong, Y. Bao, X.Z. Yang, et al., Adv. Drug Delivery Rev. 78 (2014) 63–76 doi: 10.1016/j.addr.2014.02.002
7. [7]
  K. Dillen, C. Bridts, P. Van der Veken, et al., Int. J. Pharm. 349 (2008) 234–240 doi: 10.1016/j.ijpharm.2007.07.041
8. [8]
  C. Liu, H. Shen, S. Wang, et al., Chin. Chem. Lett. 29 (2018) 1824–1828 doi: 10.1016/j.cclet.2018.10.025
9. [9]
  M. Yousefi, A. Ehsani, S.M. Jafari, Adv. Colloid Interface Sci. 270 (2019) 263–277 doi: 10.1016/j.cis.2019.07.005
10. [10]
  Y. Liu, D. Li, J. Ding, X. Chen, Chin. Chem. Lett. 31 (2020) 3001–3014 doi: 10.1016/j.cclet.2020.04.029
11. [11]
  Y. Zheng, H. Jiang, X. Wang, Chin. Chem. Lett. 31 (2020) 3183–3189 doi: 10.1016/j.cclet.2020.05.035
12. [12]
  X. Huang, W. Xu, M. Li, et al., Matter 4 (2021) 1892–1918 doi: 10.1016/j.matt.2021.03.016
13. [13]
  J. Zhang, C. Xiao, X. Zhang, et al., J. Control. Release 335 (2021) 359–368 doi: 10.1016/j.jconrel.2021.04.017
14. [14]
  M.J. Hajipour, K.M. Fromm, A. Akbar Ashkarran, et al., Trends Biotechnol. 30 (2012) 499–511 doi: 10.1016/j.tibtech.2012.06.004
15. [15]
  S. Fulaz, S. Vitale, L. Quinn, E. Casey, Trends Microbiol. 27 (2019) 915–926 doi: 10.1016/j.tim.2019.07.004
16. [16]
  C.H. Li, X. Chen, R.F. Landis, et al., ACS Infect. Dis. 5 (2019) 1590–1596 doi: 10.1021/acsinfecdis.9b00134
17. [17]
  U.S. Toti, B.R. Guru, M. Hali, et al., Biomaterials 32 (2011) 6606–6613 doi: 10.1016/j.biomaterials.2011.05.038
18. [18]
  F. Danhier, E. Ansorena, J.M. Silva, et al., J. Control. Release 161 (2012) 505–522 doi: 10.1016/j.jconrel.2012.01.043
19. [19]
  Y. Zhou, A. Fang, F. Wang, et al., Chin. Chem. Lett. 31 (2020) 494–500 doi: 10.1109/icaice51518.2020.00102
20. [20]
  A. Parodi, R. Molinaro, M. Sushnitha, et al., Biomaterials 147 (2017) 155–168 doi: 10.1016/j.biomaterials.2017.09.020
21. [21]
  Y. Chen, X. Li, M. Wang, et al., Small 16 (2020) 1906028 doi: 10.1002/smll.201906028
22. [22]
  X. Xu, Y. Jian, Y. Li, et al., ACS Nano 8 (2014) 9255–9264 doi: 10.1021/nn503118f
23. [23]
  Z. Zhang, X. Zhang, X. Xu, et al., Adv. Funct. Mater. 25 (2015) 5250–5260 doi: 10.1002/adfm.201502049
24. [24]
  Y. Li, X. Xu, X. Zhang, et al., ACS Nano 11 (2017) 416–429 doi: 10.1021/acsnano.6b06161
25. [25]
  Y. Li, X. Zhang, Z. Zhang, et al., Mater. Horiz. 5 (2018) 1047–1057 doi: 10.1039/c8mh00694f
26. [26]
  X. Zhang, X. Xu, Y. Li, et al., Adv. Mater. 30 (2018) 1707240 doi: 10.1002/adma.201707240
27. [27]
  Y. Li, X. Xu, J. Control. Release 323 (2020) 483–501 doi: 10.1016/j.jconrel.2020.05.007
28. [28]
  Q. Xu, C. Shu, Y. Li, et al., Chem. Commun. 57 (2021) 4859–4862 doi: 10.1039/d0cc07953g
29. [29]
  P. Wang, S. Jiang, Y. Li, et al., Nanomedicine NBM 34 (2021) 102381 doi: 10.1016/j.nano.2021.102381
30. [30]
  G. Yang, S.Z.F. Phua, A.K. Bindra, Y. Zhao, Adv. Mater. 31 (2019) 1805730 doi: 10.1002/adma.201805730
31. [31]
  M.N.V. Ravi Kumar, U. Bakowsky, C.M. Lehr, Biomaterials 25 (2004) 1771–1777 doi: 10.1016/j.biomaterials.2003.08.069
32. [32]
  S.E. Birk, A. Boisen, L.H. Nielsen, Adv. Drug Delivery Rev. 174 (2021) 30–52 doi: 10.1016/j.addr.2021.04.005
1. [1]
  Jing Zhang , Charles Wang , Yaoyao Zhang , Haining Xia , Yujuan Wang , Kun Ma , Junfeng Wang . Application of magnetotactic bacteria as engineering microrobots: Higher delivery efficiency of antitumor medicine. Chinese Chemical Letters, 2024, 35(10): 109420-. doi: 10.1016/j.cclet.2023.109420
2. [2]
  Yujie Li , Ya-Nan Wang , Yin-Gen Luo , Hongcai Yang , Jinrui Ren , Xiao Li . Advances in synthetic biology-based drug delivery systems for disease treatment. Chinese Chemical Letters, 2024, 35(11): 109576-. doi: 10.1016/j.cclet.2024.109576
3. [3]
  Ziheng Zhuang , Xiao Xu , Kin Shing Chan . Superdrugs for Superbugs. University Chemistry, 2024, 39(9): 128-133. doi: 10.3866/PKU.DXHX202309040
4. [4]
  Jiajia Wang , XinXin Ge , Yajing Xiang , Xiaoliang Qi , Ying Li , Hangbin Xu , Erya Cai , Chaofan Zhang , Yulong Lan , Xiaojing Chen , Yizuo Shi , Zhangping Li , Jianliang Shen . An ionic liquid functionalized sericin hydrogel for drug-resistant bacteria-infected diabetic wound healing. Chinese Chemical Letters, 2025, 36(2): 109819-. doi: 10.1016/j.cclet.2024.109819
5. [5]
  Qihang Wu , Hui Wen , Wenhai Lin , Tingting Sun , Zhigang Xie . Alkyl chain engineering of boron dipyrromethenes for efficient photodynamic antibacterial treatment. Chinese Chemical Letters, 2024, 35(12): 109692-. doi: 10.1016/j.cclet.2024.109692
6. [6]
  Zhipeng Li , Qincong Feng , Jianliang Shen . A β-lactamase-activatable photosensitizer for the treatment of resistant bacterial infections. Chinese Chemical Letters, 2024, 35(11): 109602-. doi: 10.1016/j.cclet.2024.109602
7. [7]
  Wei Su , Xiaoyan Luo , Peiyuan Li , Ying Zhang , Chenxiang Lin , Kang Wang , Jianzhuang Jiang . Phthalocyanine self-assembled nanoparticles for type Ⅰ photodynamic antibacterial therapy. Chinese Chemical Letters, 2024, 35(12): 109522-. doi: 10.1016/j.cclet.2024.109522
8. [8]
  Chaohui Zheng , Jing Xi , Shiyi Long , Tianpei He , Rui Zhao , Xinyuan Luo , Na Chen , Quan Yuan . Persistent luminescence encoding for rapid and accurate oral-derived bacteria identification. Chinese Chemical Letters, 2025, 36(1): 110223-. doi: 10.1016/j.cclet.2024.110223
9. [9]
  Feihu Wu , Gengwen Chen , Kaitao Lai , Shiqing Zhang , Yingchao Liu , Ruijian Luo , Xiaocong Wang , Pinzhi Cao , Yi Ye , Jiarong Lian , Junle Qu , Zhigang Yang , Xiaojun Peng . Non-specific/specific SERS spectra concatenation for precise bacteria classifications with few samples using a residual neural network. Chinese Chemical Letters, 2025, 36(1): 109884-. doi: 10.1016/j.cclet.2024.109884
10. [10]
  Linghui Zou , Meng Cheng , Kaili Hu , Jianfang Feng , Liangxing Tu . Vesicular drug delivery systems for oral absorption enhancement. Chinese Chemical Letters, 2024, 35(7): 109129-. doi: 10.1016/j.cclet.2023.109129
11. [11]
  Fengjie Liu , Fansu Meng , Zhenjiang Yang , Huan Wang , Yuehong Ren , Yu Cai , Xingwang Zhang . Exosome-biomimetic nanocarriers for oral drug delivery. Chinese Chemical Letters, 2024, 35(9): 109335-. doi: 10.1016/j.cclet.2023.109335
12. [12]
  Dexuan Xiao , Tianyu Chen , Tianxu Zhang , Sirong Shi , Mei Zhang , Xin Qin , Yunkun Liu , Longjiang Li , Yunfeng Lin . Transdermal treatment for malignant melanoma by aptamer-modified tetrahedral framework nucleic acid delivery of vemurafenib. Chinese Chemical Letters, 2024, 35(4): 108602-. doi: 10.1016/j.cclet.2023.108602
13. [13]
  Yiran Tao , Chunlei Dai , Zhaoxiang Xie , Xinru You , Kaiwen Li , Jun Wu , Hai Huang . Redox responsive polymeric nanoparticles enhance the efficacy of cyclin dependent kinase 7 inhibitor for enhanced treatment of prostate cancer. Chinese Chemical Letters, 2024, 35(8): 109170-. doi: 10.1016/j.cclet.2023.109170
14. [14]
  Tong Tong , Lezong Chen , Siying Wu , Zhong Cao , Yuanbin Song , Jun Wu . Establishment of a leucine-based poly(ester amide)s library with self-anticancer effect as nano-drug carrier for colorectal cancer treatment. Chinese Chemical Letters, 2024, 35(12): 109689-. doi: 10.1016/j.cclet.2024.109689
15. [15]
  Yunjie Dang , Yanru Feng , Xiao Chen , Chaoxing He , Shujie Wei , Dingyang Liu , Jinlong Qi , Huaxing Zhang , Shaokun Yang , Zhiyun Niu , Bai Xiang . Development of a multi-level pH-responsive lipid nanoplatform for efficient co-delivery of siRNA and small-molecule drugs in tumor treatment. Chinese Chemical Letters, 2024, 35(12): 109660-. doi: 10.1016/j.cclet.2024.109660
16. [16]
  Jisheng Liu , Junli Chen , Xifeng Zhang , Yin Wu , Xin Qi , Jie Wang , Xiang Gao . Red blood cell membrane-coated FLT3 inhibitor nanoparticles to enhance FLT3-ITD acute myeloid leukemia treatment. Chinese Chemical Letters, 2024, 35(9): 109779-. doi: 10.1016/j.cclet.2024.109779
17. [17]
  Ningyue Xu , Jun Wang , Lei Liu , Changyang Gong . Injectable hydrogel-based drug delivery systems for enhancing the efficacy of radiation therapy: A review of recent advances. Chinese Chemical Letters, 2024, 35(8): 109225-. doi: 10.1016/j.cclet.2023.109225
18. [18]
  Zhilong Xie , Guohui Zhang , Ya Meng , Yefei Tong , Jian Deng , Honghui Li , Qingqing Ma , Shisong Han , Wenjun Ni . A natural nano-platform: Advances in drug delivery system with recombinant high-density lipoprotein. Chinese Chemical Letters, 2024, 35(11): 109584-. doi: 10.1016/j.cclet.2024.109584
19. [19]
  Yi Cao , Xiaojiao Ge , Yuanyuan Wei , Lulu He , Aiguo Wu , Juan Li . Tumor microenvironment-activatable neuropeptide-drug conjugates enhanced tumor penetration and inhibition via multiple delivery pathways and calcium deposition. Chinese Chemical Letters, 2024, 35(4): 108672-. doi: 10.1016/j.cclet.2023.108672
20. [20]
  Jiechen Liu , Xiaoguang Li , Ruiyang Xia , Yuqi Wang , Fenghe Zhang , Yongzhi Pang , Qing Li . Efficient suppression of oral squamous cell carcinoma through spatial dimension conversion drug delivery systems-enabled immunomodulatory-photodynamic therapy. Chinese Chemical Letters, 2024, 35(12): 109619-. doi: 10.1016/j.cclet.2024.109619

Get Citation

PDF

XML

Metrics

PDF Downloads(6)
Abstract views(550)
HTML views(75)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142